Global Antidiabetic Thiazolidinediones Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
Table of Contents1 Report Overview
1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global Antidiabetic Thiazolidinediones Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Rosiglitazone
1.2.3 Pioglitazone
1.3 Market Segment by Application
1.3.1 Global Antidiabetic Thiazolidinediones Market Share by Application (2017 VS 2021 VS 2028)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Antidiabetic Thiazolidinediones Market Size (2017-2028)
2.1.1 Global Antidiabetic Thiazolidinediones Revenue (2017-2028)
2.1.2 Global Antidiabetic Thiazolidinediones Sales (2017-2028)
2.2 Global Antidiabetic Thiazolidinediones Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.2.1 Global Antidiabetic Thiazolidinediones Sales by Regions (2017-2022)
2.2.2 Global Antidiabetic Thiazolidinediones Revenue by Regions (2017-2022)
2.3 Global Antidiabetic Thiazolidinediones Market Size Forecast by Region
2.3.1 Global Antidiabetic Thiazolidinediones Sales Forecast by Region (2023-2028)
2.3.2 Global Antidiabetic Thiazolidinediones Revenue Forecast by Region (2023-2028)
2.4 Global Top Antidiabetic Thiazolidinediones Regions (Countries) Ranking by Market Size
2.5 Antidiabetic Thiazolidinediones Market Dynamics
2.5.1 Antidiabetic Thiazolidinediones Market Trends
2.5.2 Antidiabetic Thiazolidinediones Market Drivers
2.5.3 Antidiabetic Thiazolidinediones Market Challenges
2.5.4 Antidiabetic Thiazolidinediones Market Restraints
3 Competitive Landscape by Manufacturers
3.1 Global Top Antidiabetic Thiazolidinediones Manufacturers by Sales (2017-2022)
3.1.1 Global Antidiabetic Thiazolidinediones Sales by Manufacturers (2017-2022)
3.1.2 Global Antidiabetic Thiazolidinediones Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global 5 and 10 Largest Manufacturers by Antidiabetic Thiazolidinediones Sales in 2021
3.2 Global Top Manufacturers Antidiabetic Thiazolidinediones by Revenue
3.2.1 Global Antidiabetic Thiazolidinediones Revenue by Manufacturers (2017-2022)
3.2.2 Top Antidiabetic Thiazolidinediones Manufacturers Covered: Ranking by Revenue
3.2.3 Global Antidiabetic Thiazolidinediones Revenue Share by Manufacturers (2017-2022)
3.2.4 Global Antidiabetic Thiazolidinediones Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Antidiabetic Thiazolidinediones as of 2021)
3.4 Global Antidiabetic Thiazolidinediones Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Antidiabetic Thiazolidinediones Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Antidiabetic Thiazolidinediones Market
3.7 Key Manufacturers Antidiabetic Thiazolidinediones Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Antidiabetic Thiazolidinediones Market Size by Type
4.1 Global Antidiabetic Thiazolidinediones Historic Market Review by Type (2017-2022)
4.1.1 Global Antidiabetic Thiazolidinediones Sales Market Share by Type (2017-2022)
4.1.2 Global Antidiabetic Thiazolidinediones Revenue Market Share by Type (2017-2022)
4.1.3 Antidiabetic Thiazolidinediones Price by Type (2017-2022)
4.2 Global Antidiabetic Thiazolidinediones Market Estimates and Forecasts by Type (2023-2028)
4.2.1 Global Antidiabetic Thiazolidinediones Sales Forecast by Type (2023-2028)
4.2.2 Global Antidiabetic Thiazolidinediones Revenue Forecast by Type (2023-2028)
4.2.3 Antidiabetic Thiazolidinediones Price Forecast by Type (2023-2028)
5 Global Antidiabetic Thiazolidinediones Market Size by Application
5.1 Global Antidiabetic Thiazolidinediones Historic Market Review by Application (2017-2022)
5.1.1 Global Antidiabetic Thiazolidinediones Sales Market Share by Application (2017-2022)
5.1.2 Global Antidiabetic Thiazolidinediones Revenue Market Share by Application (2017-2022)
5.1.3 Antidiabetic Thiazolidinediones Price by Application (2017-2022)
5.2 Global Antidiabetic Thiazolidinediones Market Estimates and Forecasts by Application (2023-2028)
5.2.1 Global Antidiabetic Thiazolidinediones Sales Forecast by Application (2023-2028)
5.2.2 Global Antidiabetic Thiazolidinediones Revenue Forecast by Application (2023-2028)
5.2.3 Antidiabetic Thiazolidinediones Price Forecast by Application (2023-2028)
6 North America
6.1 North America Antidiabetic Thiazolidinediones Sales Breakdown by Company
6.1.1 North America Antidiabetic Thiazolidinediones Sales by Company (2017-2022)
6.1.2 North America Antidiabetic Thiazolidinediones Revenue by Company (2017-2022)
6.2 North America Antidiabetic Thiazolidinediones Market Size by Type
6.2.1 North America Antidiabetic Thiazolidinediones Sales by Type (2017-2028)
6.2.2 North America Antidiabetic Thiazolidinediones Revenue by Type (2017-2028)
6.3 North America Antidiabetic Thiazolidinediones Market Size by Application
6.3.1 North America Antidiabetic Thiazolidinediones Sales by Application (2017-2028)
6.3.2 North America Antidiabetic Thiazolidinediones Revenue by Application (2017-2028)
6.4 North America Antidiabetic Thiazolidinediones Market Size by Country
6.4.1 North America Antidiabetic Thiazolidinediones Sales by Country (2017-2028)
6.4.2 North America Antidiabetic Thiazolidinediones Revenue by Country (2017-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Antidiabetic Thiazolidinediones Sales Breakdown by Company
7.1.1 Europe Antidiabetic Thiazolidinediones Sales by Company (2017-2022)
7.1.2 Europe Antidiabetic Thiazolidinediones Revenue by Company (2017-2022)
7.2 Europe Antidiabetic Thiazolidinediones Market Size by Type
7.2.1 Europe Antidiabetic Thiazolidinediones Sales by Type (2017-2028)
7.2.2 Europe Antidiabetic Thiazolidinediones Revenue by Type (2017-2028)
7.3 Europe Antidiabetic Thiazolidinediones Market Size by Application
7.3.1 Europe Antidiabetic Thiazolidinediones Sales by Application (2017-2028)
7.3.2 Europe Antidiabetic Thiazolidinediones Revenue by Application (2017-2028)
7.4 Europe Antidiabetic Thiazolidinediones Market Size by Country
7.4.1 Europe Antidiabetic Thiazolidinediones Sales by Country (2017-2028)
7.4.2 Europe Antidiabetic Thiazolidinediones Revenue by Country (2017-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Antidiabetic Thiazolidinediones Sales Breakdown by Company
8.1.1 Asia Pacific Antidiabetic Thiazolidinediones Sales by Company (2017-2022)
8.1.2 Asia Pacific Antidiabetic Thiazolidinediones Revenue by Company (2017-2022)
8.2 Asia Pacific Antidiabetic Thiazolidinediones Market Size by Type
8.2.1 Asia Pacific Antidiabetic Thiazolidinediones Sales by Type (2017-2028)
8.2.2 Asia Pacific Antidiabetic Thiazolidinediones Revenue by Type (2017-2028)
8.3 Asia Pacific Antidiabetic Thiazolidinediones Market Size by Application
8.3.1 Asia Pacific Antidiabetic Thiazolidinediones Sales by Application (2017-2028)
8.3.2 Asia Pacific Antidiabetic Thiazolidinediones Revenue by Application (2017-2028)
8.4 Asia Pacific Antidiabetic Thiazolidinediones Market Size by Region
8.4.1 Asia Pacific Antidiabetic Thiazolidinediones Sales by Region
8.4.2 Asia Pacific Antidiabetic Thiazolidinediones Revenue by Region
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 China Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
9 Latin America
9.1 Latin America Antidiabetic Thiazolidinediones Sales Breakdown by Company
9.1.1 Latin America Antidiabetic Thiazolidinediones Sales by Company (2017-2022)
9.1.2 Latin America Antidiabetic Thiazolidinediones Revenue by Company (2017-2022)
9.2 Latin America Antidiabetic Thiazolidinediones Market Size by Type
9.2.1 Latin America Antidiabetic Thiazolidinediones Sales by Type (2017-2028)
9.2.2 Latin America Antidiabetic Thiazolidinediones Revenue by Type (2017-2028)
9.3 Latin America Antidiabetic Thiazolidinediones Market Size by Application
9.3.1 Latin America Antidiabetic Thiazolidinediones Sales by Application (2017-2028)
9.3.2 Latin America Antidiabetic Thiazolidinediones Revenue by Application (2017-2028)
9.4 Latin America Antidiabetic Thiazolidinediones Market Size by Country
9.4.1 Latin America Antidiabetic Thiazolidinediones Sales by Country (2017-2028)
9.4.2 Latin America Antidiabetic Thiazolidinediones Revenue by Country (2017-2028)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Antidiabetic Thiazolidinediones Sales Breakdown by Company
10.1.1 Middle East and Africa Antidiabetic Thiazolidinediones Sales by Company (2017-2022)
10.1.2 Middle East and Africa Antidiabetic Thiazolidinediones Revenue by Company (2017-2022)
10.2 Middle East and Africa Antidiabetic Thiazolidinediones Market Size by Type
10.2.1 Middle East and Africa Antidiabetic Thiazolidinediones Sales by Type (2017-2028)
10.2.2 Middle East and Africa Antidiabetic Thiazolidinediones Revenue by Type (2017-2028)
10.3 Middle East and Africa Antidiabetic Thiazolidinediones Market Size by Application
10.3.1 Middle East and Africa Antidiabetic Thiazolidinediones Sales by Application (2017-2028)
10.3.2 Middle East and Africa Antidiabetic Thiazolidinediones Revenue by Application (2017-2028)
10.4 Middle East and Africa Antidiabetic Thiazolidinediones Market Size by Country
10.4.1 Middle East and Africa Antidiabetic Thiazolidinediones Sales by Country (2017-2028)
10.4.2 Middle East and Africa Antidiabetic Thiazolidinediones Revenue by Country (2017-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Company Profiles
11.1 Sanofi
11.1.1 Sanofi Corporation Information
11.1.2 Sanofi Overview
11.1.3 Sanofi Antidiabetic Thiazolidinediones Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.1.4 Sanofi Antidiabetic Thiazolidinediones Products and Services
11.1.5 Sanofi Antidiabetic Thiazolidinediones SWOT Analysis
11.1.6 Sanofi Recent Developments
11.2 Takeda Pharmaceuticals
11.2.1 Takeda Pharmaceuticals Corporation Information
11.2.2 Takeda Pharmaceuticals Overview
11.2.3 Takeda Pharmaceuticals Antidiabetic Thiazolidinediones Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.2.4 Takeda Pharmaceuticals Antidiabetic Thiazolidinediones Products and Services
11.2.5 Takeda Pharmaceuticals Antidiabetic Thiazolidinediones SWOT Analysis
11.2.6 Takeda Pharmaceuticals Recent Developments
11.3 Eli Lilly
11.3.1 Eli Lilly Corporation Information
11.3.2 Eli Lilly Overview
11.3.3 Eli Lilly Antidiabetic Thiazolidinediones Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.3.4 Eli Lilly Antidiabetic Thiazolidinediones Products and Services
11.3.5 Eli Lilly Antidiabetic Thiazolidinediones SWOT Analysis
11.3.6 Eli Lilly Recent Developments
11.4 Merck & Co.
11.4.1 Merck & Co. Corporation Information
11.4.2 Merck & Co. Overview
11.4.3 Merck & Co. Antidiabetic Thiazolidinediones Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.4.4 Merck & Co. Antidiabetic Thiazolidinediones Products and Services
11.4.5 Merck & Co. Antidiabetic Thiazolidinediones SWOT Analysis
11.4.6 Merck & Co. Recent Developments
11.5 Novo Nordisk
11.5.1 Novo Nordisk Corporation Information
11.5.2 Novo Nordisk Overview
11.5.3 Novo Nordisk Antidiabetic Thiazolidinediones Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.5.4 Novo Nordisk Antidiabetic Thiazolidinediones Products and Services
11.5.5 Novo Nordisk Antidiabetic Thiazolidinediones SWOT Analysis
11.5.6 Novo Nordisk Recent Developments
11.6 Bristol-Myers Squibb
11.6.1 Bristol-Myers Squibb Corporation Information
11.6.2 Bristol-Myers Squibb Overview
11.6.3 Bristol-Myers Squibb Antidiabetic Thiazolidinediones Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.6.4 Bristol-Myers Squibb Antidiabetic Thiazolidinediones Products and Services
11.6.5 Bristol-Myers Squibb Antidiabetic Thiazolidinediones SWOT Analysis
11.6.6 Bristol-Myers Squibb Recent Developments
11.7 Pfizer
11.7.1 Pfizer Corporation Information
11.7.2 Pfizer Overview
11.7.3 Pfizer Antidiabetic Thiazolidinediones Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.7.4 Pfizer Antidiabetic Thiazolidinediones Products and Services
11.7.5 Pfizer Antidiabetic Thiazolidinediones SWOT Analysis
11.7.6 Pfizer Recent Developments
11.8 AstraZeneca
11.8.1 AstraZeneca Corporation Information
11.8.2 AstraZeneca Overview
11.8.3 AstraZeneca Antidiabetic Thiazolidinediones Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.8.4 AstraZeneca Antidiabetic Thiazolidinediones Products and Services
11.8.5 AstraZeneca Antidiabetic Thiazolidinediones SWOT Analysis
11.8.6 AstraZeneca Recent Developments
11.9 GlaxoSmithKline
11.9.1 GlaxoSmithKline Corporation Information
11.9.2 GlaxoSmithKline Overview
11.9.3 GlaxoSmithKline Antidiabetic Thiazolidinediones Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.9.4 GlaxoSmithKline Antidiabetic Thiazolidinediones Products and Services
11.9.5 GlaxoSmithKline Antidiabetic Thiazolidinediones SWOT Analysis
11.9.6 GlaxoSmithKline Recent Developments
11.10 Boehringer Ingelheim
11.10.1 Boehringer Ingelheim Corporation Information
11.10.2 Boehringer Ingelheim Overview
11.10.3 Boehringer Ingelheim Antidiabetic Thiazolidinediones Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.10.4 Boehringer Ingelheim Antidiabetic Thiazolidinediones Products and Services
11.10.5 Boehringer Ingelheim Antidiabetic Thiazolidinediones SWOT Analysis
11.10.6 Boehringer Ingelheim Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Antidiabetic Thiazolidinediones Value Chain Analysis
12.2 Antidiabetic Thiazolidinediones Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Antidiabetic Thiazolidinediones Production Mode & Process
12.4 Antidiabetic Thiazolidinediones Sales and Marketing
12.4.1 Antidiabetic Thiazolidinediones Sales Channels
12.4.2 Antidiabetic Thiazolidinediones Distributors
12.5 Antidiabetic Thiazolidinediones Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
List of TablesTable 1. Global Antidiabetic Thiazolidinediones Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Rosiglitazone
Table 3. Major Manufacturers of Pioglitazone
Table 4. Global Antidiabetic Thiazolidinediones Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Antidiabetic Thiazolidinediones Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 6. Global Antidiabetic Thiazolidinediones Sales by Region (2017-2022) & (K Pcs)
Table 7. Global Antidiabetic Thiazolidinediones Sales Market Share by Region (2017-2022)
Table 8. Global Antidiabetic Thiazolidinediones Revenue by Region (2017-2022) & (US$ Million)
Table 9. Global Antidiabetic Thiazolidinediones Revenue Market Share by Region (2017-2022)
Table 10. Global Antidiabetic Thiazolidinediones Sales Forecast by Region (2023-2028) & (K Pcs)
Table 11. Global Antidiabetic Thiazolidinediones Sales Market Share Forecast by Region (2023-2028)
Table 12. Global Antidiabetic Thiazolidinediones Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 13. Global Antidiabetic Thiazolidinediones Revenue Market Share Forecast by Region (2023-2028)
Table 14. Top Antidiabetic Thiazolidinediones Regions (Countries) Ranking by Market Size (US$ Million) in 2021
Table 15. Antidiabetic Thiazolidinediones Market Trends
Table 16. Antidiabetic Thiazolidinediones Market Drivers
Table 17. Antidiabetic Thiazolidinediones Market Challenges
Table 18. Antidiabetic Thiazolidinediones Market Restraints
Table 19. Global Antidiabetic Thiazolidinediones Sales by Manufacturers (2017-2022) & (K Pcs)
Table 20. Global Antidiabetic Thiazolidinediones Sales Share by Manufacturers (2017-2022)
Table 21. Global Antidiabetic Thiazolidinediones Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 22. Ranking of Global Top Antidiabetic Thiazolidinediones Manufacturers by Revenue (US$ Million) in 2021
Table 23. Antidiabetic Thiazolidinediones Revenue Share by Manufacturers (2017-2022)
Table 24. Global Antidiabetic Thiazolidinediones Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 25. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Antidiabetic Thiazolidinediones as of 2021)
Table 26. Key Manufacturers Antidiabetic Thiazolidinediones Average Selling Price (ASP) & (2017-2022) & (USD/Pcs)
Table 27. Key Manufacturers Antidiabetic Thiazolidinediones Plants/Factories Distribution
Table 28. Key Manufacturers Antidiabetic Thiazolidinediones Area Served
Table 29. Date of Key Manufacturers Enter into Antidiabetic Thiazolidinediones Market
Table 30. Key Manufacturers Antidiabetic Thiazolidinediones Product Type
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Antidiabetic Thiazolidinediones Sales (K Pcs) by Type (2017-2022)
Table 33. Global Antidiabetic Thiazolidinediones Sales Share by Type (2017-2022)
Table 34. Global Antidiabetic Thiazolidinediones Revenue (US$ Million) Market Share by Type (2017-2022)
Table 35. Global Antidiabetic Thiazolidinediones Price (K Pcs) by Type (2017-2022)
Table 36. Global Antidiabetic Thiazolidinediones Sales (K Pcs) by Type (2023-2028)
Table 37. Global Antidiabetic Thiazolidinediones Sales Share by Type (2023-2028)
Table 38. Global Antidiabetic Thiazolidinediones Revenue (US$ Million) Market Share by Type (2023-2028)
Table 39. Global Antidiabetic Thiazolidinediones Revenue Share by Type (2023-2028)
Table 40. Global Antidiabetic Thiazolidinediones Price (K Pcs) by Type (2023-2028)
Table 41. Global Antidiabetic Thiazolidinediones Sales (K Pcs) by Application (2017-2022)
Table 42. Global Antidiabetic Thiazolidinediones Sales Share by Application (2017-2022)
Table 43. Global Antidiabetic Thiazolidinediones Revenue (US$ Million) Market Share by Application (2017-2022)
Table 44. Global Antidiabetic Thiazolidinediones Price (K Pcs) by Application (2017-2022)
Table 45. Global Antidiabetic Thiazolidinediones Sales (K Pcs) by Application (2023-2028)
Table 46. Global Antidiabetic Thiazolidinediones Sales Share by Application (2023-2028)
Table 47. Global Antidiabetic Thiazolidinediones Revenue (US$ Million) Market Share by Application (2023-2028)
Table 48. Global Antidiabetic Thiazolidinediones Revenue Share by Application (2023-2028)
Table 49. Global Antidiabetic Thiazolidinediones Price (K Pcs) by Application (2023-2028)
Table 50. North America Antidiabetic Thiazolidinediones Sales by Company (2017-2022) & (K Pcs)
Table 51. North America Antidiabetic Thiazolidinediones Sales Market Share by Company (2017-2022)
Table 52. North America Antidiabetic Thiazolidinediones Revenue by Company (2017-2022) & (US$ Million)
Table 53. North America Antidiabetic Thiazolidinediones Revenue Market Share by Company (2017-2022)
Table 54. North America Antidiabetic Thiazolidinediones Sales by Type (2017-2022) & (K Pcs)
Table 55. North America Antidiabetic Thiazolidinediones Sales by Type (2023-2028) & (K Pcs)
Table 56. North America Antidiabetic Thiazolidinediones Revenue by Type (2017-2022) & (US$ Million)
Table 57. North America Antidiabetic Thiazolidinediones Revenue by Type (2023-2028) & (US$ Million)
Table 58. North America Antidiabetic Thiazolidinediones Sales by Application (2017-2022) & (K Pcs)
Table 59. North America Antidiabetic Thiazolidinediones Sales by Application (2023-2028) & (K Pcs)
Table 60. North America Antidiabetic Thiazolidinediones Revenue by Application (2017-2022) & (US$ Million)
Table 61. North America Antidiabetic Thiazolidinediones Revenue by Application (2023-2028) & (US$ Million)
Table 62. North America Antidiabetic Thiazolidinediones Sales by Country (2017-2022) & (K Pcs)
Table 63. North America Antidiabetic Thiazolidinediones Sales by Country (2023-2028) & (K Pcs)
Table 64. North America Antidiabetic Thiazolidinediones Revenue by Country (2017-2022) & (US$ Million)
Table 65. North America Antidiabetic Thiazolidinediones Revenue by Country (2023-2028) & (US$ Million)
Table 66. Europe Antidiabetic Thiazolidinediones Sales by Company (2017-2022) & (K Pcs)
Table 67. Europe Antidiabetic Thiazolidinediones Sales Market Share by Company (2017-2022)
Table 68. Europe Antidiabetic Thiazolidinediones Revenue by Company (2017-2022) & (US$ Million)
Table 69. Europe Antidiabetic Thiazolidinediones Revenue Market Share by Company (2017-2022)
Table 70. Europe Antidiabetic Thiazolidinediones Sales by Type (2017-2022) & (K Pcs)
Table 71. Europe Antidiabetic Thiazolidinediones Sales by Type (2023-2028) & (K Pcs)
Table 72. Europe Antidiabetic Thiazolidinediones Revenue by Type (2017-2022) & (US$ Million)
Table 73. Europe Antidiabetic Thiazolidinediones Revenue by Type (2023-2028) & (US$ Million)
Table 74. Europe Antidiabetic Thiazolidinediones Sales by Application (2017-2022) & (K Pcs)
Table 75. Europe Antidiabetic Thiazolidinediones Sales by Application (2023-2028) & (K Pcs)
Table 76. Europe Antidiabetic Thiazolidinediones Revenue by Application (2017-2022) & (US$ Million)
Table 77. Europe Antidiabetic Thiazolidinediones Revenue by Application (2023-2028) & (US$ Million)
Table 78. Europe Antidiabetic Thiazolidinediones Sales by Country (2017-2022) & (K Pcs)
Table 79. Europe Antidiabetic Thiazolidinediones Sales by Country (2023-2028) & (K Pcs)
Table 80. Europe Antidiabetic Thiazolidinediones Revenue by Country (2017-2022) & (US$ Million)
Table 81. Europe Antidiabetic Thiazolidinediones Revenue by Country (2023-2028) & (US$ Million)
Table 82. Asia Pacific Antidiabetic Thiazolidinediones Sales by Company (2017-2022) & (K Pcs)
Table 83. Asia Pacific Antidiabetic Thiazolidinediones Sales Market Share by Company (2017-2022)
Table 84. Asia Pacific Antidiabetic Thiazolidinediones Revenue by Company (2017-2022) & (US$ Million)
Table 85. Asia Pacific Antidiabetic Thiazolidinediones Revenue Market Share by Company (2017-2022)
Table 86. Asia Pacific Antidiabetic Thiazolidinediones Sales by Type (2017-2022) & (K Pcs)
Table 87. Asia Pacific Antidiabetic Thiazolidinediones Sales by Type (2023-2028) & (K Pcs)
Table 88. Asia Pacific Antidiabetic Thiazolidinediones Revenue by Type (2017-2022) & (US$ Million)
Table 89. Asia Pacific Antidiabetic Thiazolidinediones Revenue by Type (2023-2028) & (US$ Million)
Table 90. Asia Pacific Antidiabetic Thiazolidinediones Sales by Application (2017-2022) & (K Pcs)
Table 91. Asia Pacific Antidiabetic Thiazolidinediones Sales by Application (2023-2028) & (K Pcs)
Table 92. Asia Pacific Antidiabetic Thiazolidinediones Revenue by Application (2017-2022) & (US$ Million)
Table 93. Asia Pacific Antidiabetic Thiazolidinediones Revenue by Application (2023-2028) & (US$ Million)
Table 94. Asia Pacific Antidiabetic Thiazolidinediones Sales by Region (2017-2022) & (K Pcs)
Table 95. Asia Pacific Antidiabetic Thiazolidinediones Sales by Region (2023-2028) & (K Pcs)
Table 96. Asia Pacific Antidiabetic Thiazolidinediones Revenue by Region (2017-2022) & (US$ Million)
Table 97. Asia Pacific Antidiabetic Thiazolidinediones Revenue by Region (2023-2028) & (US$ Million)
Table 98. Latin America Antidiabetic Thiazolidinediones Sales by Company (2017-2022) & (K Pcs)
Table 99. Latin America Antidiabetic Thiazolidinediones Sales Market Share by Company (2017-2022)
Table 100. Latin America Antidiabetic Thiazolidinediones Revenue by Company (2017-2022) & (US$ Million)
Table 101. Latin America Antidiabetic Thiazolidinediones Revenue Market Share by Company (2017-2022)
Table 102. Latin America Antidiabetic Thiazolidinediones Sales by Type (2017-2022) & (K Pcs)
Table 103. Latin America Antidiabetic Thiazolidinediones Sales by Type (2023-2028) & (K Pcs)
Table 104. Latin America Antidiabetic Thiazolidinediones Revenue by Type (2017-2022) & (US$ Million)
Table 105. Latin America Antidiabetic Thiazolidinediones Revenue by Type (2023-2028) & (US$ Million)
Table 106. Latin America Antidiabetic Thiazolidinediones Sales by Application (2017-2022) & (K Pcs)
Table 107. Latin America Antidiabetic Thiazolidinediones Sales by Application (2023-2028) & (K Pcs)
Table 108. Latin America Antidiabetic Thiazolidinediones Revenue by Application (2017-2022) & (US$ Million)
Table 109. Latin America Antidiabetic Thiazolidinediones Revenue by Application (2023-2028) & (US$ Million)
Table 110. Latin America Antidiabetic Thiazolidinediones Sales by Country (2017-2022) & (K Pcs)
Table 111. Latin America Antidiabetic Thiazolidinediones Sales by Country (2023-2028) & (K Pcs)
Table 112. Latin America Antidiabetic Thiazolidinediones Revenue by Country (2017-2022) & (US$ Million)
Table 113. Latin America Antidiabetic Thiazolidinediones Revenue by Country (2023-2028) & (US$ Million)
Table 114. Middle East and Africa Antidiabetic Thiazolidinediones Sales by Company (2017-2022) & (K Pcs)
Table 115. Middle East and Africa Antidiabetic Thiazolidinediones Sales Market Share by Company (2017-2022)
Table 116. Middle East and Africa Antidiabetic Thiazolidinediones Revenue by Company (2017-2022) & (US$ Million)
Table 117. Middle East and Africa Antidiabetic Thiazolidinediones Revenue Market Share by Company (2017-2022)
Table 118. Middle East and Africa Antidiabetic Thiazolidinediones Sales by Type (2017-2022) & (K Pcs)
Table 119. Middle East and Africa Antidiabetic Thiazolidinediones Sales by Type (2023-2028) & (K Pcs)
Table 120. Middle East and Africa Antidiabetic Thiazolidinediones Revenue by Type (2017-2022) & (US$ Million)
Table 121. Middle East and Africa Antidiabetic Thiazolidinediones Revenue by Type (2023-2028) & (US$ Million)
Table 122. Middle East and Africa Antidiabetic Thiazolidinediones Sales by Application (2017-2022) & (K Pcs)
Table 123. Middle East and Africa Antidiabetic Thiazolidinediones Sales by Application (2023-2028) & (K Pcs)
Table 124. Middle East and Africa Antidiabetic Thiazolidinediones Revenue by Application (2017-2022) & (US$ Million)
Table 125. Middle East and Africa Antidiabetic Thiazolidinediones Revenue by Application (2023-2028) & (US$ Million)
Table 126. Middle East and Africa Antidiabetic Thiazolidinediones Sales by Country (2017-2022) & (K Pcs)
Table 127. Middle East and Africa Antidiabetic Thiazolidinediones Sales by Country (2023-2028) & (K Pcs)
Table 128. Middle East and Africa Antidiabetic Thiazolidinediones Revenue by Country (2017-2022) & (US$ Million)
Table 129. Middle East and Africa Antidiabetic Thiazolidinediones Revenue by Country (2023-2028) & (US$ Million)
Table 130. Sanofi Corporation Information
Table 131. Sanofi Description and Overview
Table 132. Sanofi Antidiabetic Thiazolidinediones Sales (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2017-2022)
Table 133. Sanofi Antidiabetic Thiazolidinediones Product and Services
Table 134. Sanofi Antidiabetic Thiazolidinediones SWOT Analysis
Table 135. Sanofi Recent Developments
Table 136. Takeda Pharmaceuticals Corporation Information
Table 137. Takeda Pharmaceuticals Description and Overview
Table 138. Takeda Pharmaceuticals Antidiabetic Thiazolidinediones Sales (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2017-2022)
Table 139. Takeda Pharmaceuticals Antidiabetic Thiazolidinediones Product and Services
Table 140. Takeda Pharmaceuticals Antidiabetic Thiazolidinediones SWOT Analysis
Table 141. Takeda Pharmaceuticals Recent Developments
Table 142. Eli Lilly Corporation Information
Table 143. Eli Lilly Description and Overview
Table 144. Eli Lilly Antidiabetic Thiazolidinediones Sales (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2017-2022)
Table 145. Eli Lilly Antidiabetic Thiazolidinediones Product and Services
Table 146. Eli Lilly Antidiabetic Thiazolidinediones SWOT Analysis
Table 147. Eli Lilly Recent Developments
Table 148. Merck & Co. Corporation Information
Table 149. Merck & Co. Description and Overview
Table 150. Merck & Co. Antidiabetic Thiazolidinediones Sales (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2017-2022)
Table 151. Merck & Co. Antidiabetic Thiazolidinediones Product and Services
Table 152. Merck & Co. Antidiabetic Thiazolidinediones SWOT Analysis
Table 153. Merck & Co. Recent Developments
Table 154. Novo Nordisk Corporation Information
Table 155. Novo Nordisk Description and Overview
Table 156. Novo Nordisk Antidiabetic Thiazolidinediones Sales (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2017-2022)
Table 157. Novo Nordisk Antidiabetic Thiazolidinediones Product and Services
Table 158. Novo Nordisk Antidiabetic Thiazolidinediones SWOT Analysis
Table 159. Novo Nordisk Recent Developments
Table 160. Bristol-Myers Squibb Corporation Information
Table 161. Bristol-Myers Squibb Description and Overview
Table 162. Bristol-Myers Squibb Antidiabetic Thiazolidinediones Sales (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2017-2022)
Table 163. Bristol-Myers Squibb Antidiabetic Thiazolidinediones Product and Services
Table 164. Bristol-Myers Squibb Antidiabetic Thiazolidinediones SWOT Analysis
Table 165. Bristol-Myers Squibb Recent Developments
Table 166. Pfizer Corporation Information
Table 167. Pfizer Description and Overview
Table 168. Pfizer Antidiabetic Thiazolidinediones Sales (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2017-2022)
Table 169. Pfizer Antidiabetic Thiazolidinediones Product and Services
Table 170. Pfizer Antidiabetic Thiazolidinediones SWOT Analysis
Table 171. Pfizer Recent Developments
Table 172. AstraZeneca Corporation Information
Table 173. AstraZeneca Description and Overview
Table 174. AstraZeneca Antidiabetic Thiazolidinediones Sales (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2017-2022)
Table 175. AstraZeneca Antidiabetic Thiazolidinediones Product and Servic